Healthcare

InfuSystem Announces Distribution Agreement with Smith+Nephew for Negative Pressure Wound Therapy System and First Shipment of NPWT Systems

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider,…

5 months ago

Astiva Health Launches Investor Relations Website, Reinforcing Commitment to Transparent Communication

ORANGE, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- via IBN - Astiva Health, a leader in innovative and culturally aware…

5 months ago

Healing Realty Trust Announces Preferred Real Estate Partnership Agreements with NeuroSpa, Cambridge Biotherapies and Cathexis to Enhance Clinic-Focused Portfolio

Jupiter, Florida--(Newsfile Corp. - August 6, 2024) - Healing Realty Trust ("HRT" or the "Company"), a data-driven, self-managed real estate…

5 months ago

Cosmos Health Reports Full Year 2023 Results: Revenue Increases to $53.4M, or 6% YoY; Stockholders’ Equity Remains Near Record Highs at $36M, or $2.25 per Share

CHICAGO, IL / ACCESSWIRE / August 6, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

5 months ago

Daxor Corporation Awarded $1.9M Contract by The U.S. Air Force for Development of its Next Generation Tracer System in its Point-of-Care Blood Volume Analyzer

Oak Ridge, TN, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement…

5 months ago

Inovalon Launches Converged Stars Health Equity Analytics To Address CMS Regulations and Empower Health Equity Index Success

First SaaS Solution for Health Plans to Address Health Disparities and Fulfill CMS Health Equity Index RequirementsBOWIE, Md., Aug. 06,…

5 months ago

iSpecimen Reports Second Quarter 2024 Results

Revenue increased 76% year-over-year to approximately $2.86 million Brielan Smiechowski Named SVP of Sales and Business Development LEXINGTON, Mass., Aug.…

5 months ago

ADC Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update

ZYNLONTA® net sales of $17.0 million in 2Q 2024; Commercial profitability achieved during first half of 2024 LOTIS-7 trial enrollment…

5 months ago

Surgery Partners, Inc. Announces Second Quarter 2024 Results Raises Full Year 2024 Guidance

BRENTWOOD, Tenn., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical…

5 months ago

Black Diamond Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Initial Phase 2 data of BDTX-1535 in 2L/3L patients with EGFRm NSCLC on track for later in Q3 2024On track…

5 months ago